Announcements Trials
Browse Landscape

Phase

Phase 1/2 1Phase 1 1

Status

Completed 2

Sponsor Class

INDUSTRY 2

Study Type

Interventional 2

Sponsor

Cancer Type

Other solid neoplasm 2

Conditions

Mesothelioma 17Mesothelioma, Malignant 15Solid Tumor 10Carcinoma, Non-Small-Cell Lung 8Advanced Solid Tumors 8Melanoma 6Carcinoma, Renal Cell 5Carcinoma, Hepatocellular 5Advanced Solid Tumor 5Solid Tumors 4Uterine Cervical Neoplasms 3Triple Negative Breast Neoplasms 3Squamous Cell Carcinoma of Head and Neck 3Small Cell Lung Carcinoma 3Ovarian Neoplasms 3Carcinoma, Transitional Cell 3Carcinoma, Merkel Cell 3Advanced or Metastatic Solid Tumors 3Turcot syndrome 2Stomach Neoplasms 2Neoplasm Metastasis 2Malignant Solid Tumor 2Lung Neoplasms 2Endometrial Neoplasms 2Colorectal Neoplasms 2Cholangiocarcinoma 2Wilms Tumor 1Vulvar Neoplasms 1Vaginal Neoplasms 1Urinary Bladder Neoplasms 1

Interventions

pembrolizumab 3Ramucirumab 2Nivolumab 2etirinotecan pegol 1cemiplimab 1Ribavirin 1Paclitaxel 1Injections 1Fluorouracil 1Docetaxel 1Decitabine 1Cisplatin 1Carboplatin 1Antibodies, Bispecific 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Malignant Solid Tumor × Nivolumab × Other solid neoplasm × Clear all
NCT02754141 2023-04-05

An Investigational Immuno-therapy Study of Experimental Medication BMS-986179 Given Alone and in Combination With Nivolumab

Bristol-Myers Squibb

Phase 1/2 Completed
235 enrolled 37 charts
Other solid neoplasm

Malignant Solid Tumor

NCT00836888 2020-10-08

ONO-4538 Phase I Study in Patients With Advanced Malignant Solid Tumors in Japan

Ono Pharmaceutical Co., Ltd.

Phase 1 Completed
17 enrolled 18 charts
Other solid neoplasm

Malignant Solid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡